Structures by: Lennie A. R.
Total: 167
C9H21Cu2N9O8
C9H21Cu2N9O8
CrystEngComm (2009) 11, 12 2601
a=15.4344(18)Å b=12.3617(6)Å c=8.7439(4)Å
α=90° β=90° γ=90°
C18H42Cu4N18O16
C18H42Cu4N18O16
CrystEngComm (2009) 11, 12 2601
a=16.3031(13)Å b=11.9204(5)Å c=17.1330(8)Å
α=90° β=114.469(5)° γ=90°
C9H21Cu2N9O8
C9H21Cu2N9O8
CrystEngComm (2009) 11, 12 2601
a=15.679(4)Å b=12.699(3)Å c=8.932(2)Å
α=90° β=90° γ=90°
C9H21Cu2N9O8
C9H21Cu2N9O8
CrystEngComm (2009) 11, 12 2601
a=15.6012(9)Å b=12.5198(3)Å c=8.8557(2)Å
α=90° β=90° γ=90°
C9H21Cu2N9O8
C9H21Cu2N9O8
CrystEngComm (2009) 11, 12 2601
a=15.0833(11)Å b=12.1396(3)Å c=8.7075(3)Å
α=90° β=90° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=13.1506(18)Å b=3.8859(6)Å c=14.3115(19)Å
α=90° β=91.548(10)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=13.249(4)Å b=3.9513(11)Å c=14.402(4)Å
α=90° β=90.324(4)° γ=90°
3-Methoxysalicylaldoxime
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=13.9108(5)Å b=7.1936(3)Å c=15.6965(6)Å
α=90° β=90° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.998(3)Å b=3.6988(5)Å c=13.9167(16)Å
α=90° β=90.99(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.941(4)Å b=3.6146(5)Å c=13.7188(17)Å
α=90° β=91.47(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.878(4)Å b=3.5363(5)Å c=13.5218(16)Å
α=90° β=91.88(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.831(3)Å b=3.5096(4)Å c=13.4462(13)Å
α=90° β=92.10(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.766(7)Å b=3.4872(9)Å c=13.382(3)Å
α=90° β=92.27(4)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.750(4)Å b=3.4482(6)Å c=13.2910(18)Å
α=90° β=92.45(2)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.811(3)Å b=6.4564(7)Å c=19.759(4)Å
α=90° β=94.060(8)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.5745(13)Å b=6.3779(4)Å c=19.0922(18)Å
α=90° β=94.882(4)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.3941(14)Å b=6.3329(4)Å c=18.7250(19)Å
α=90° β=95.325(5)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.271(4)Å b=6.3030(9)Å c=18.459(5)Å
α=90° β=95.590(15)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.101(3)Å b=6.2699(6)Å c=18.158(3)Å
α=90° β=95.817(10)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.843(3)Å b=3.6613(3)Å c=13.7921(16)Å
α=90° β=92.603(13)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.652(4)Å b=3.5295(4)Å c=13.509(2)Å
α=90° β=93.64(2)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.544(6)Å b=3.4424(8)Å c=13.365(5)Å
α=90° β=94.44(4)° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.3113(5)Å b=6.9800(4)Å c=14.8947(5)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.5814(4)Å b=7.0265(4)Å c=15.0188(4)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.1340(13)Å b=6.9421(11)Å c=14.8065(13)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.0702(5)Å b=6.9200(5)Å c=14.7703(5)Å
α=90° β=90° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=6.6132(3)Å b=13.1087(6)Å c=13.6382(6)Å
α=68.762(3)° β=76.739(3)° γ=79.733(3)°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=6.5597(7)Å b=12.8532(9)Å c=13.479(2)Å
α=69.311(10)° β=76.054(10)° γ=79.035(6)°
Cyclotrimethylene-trinitramine
C3H6N6O6
CrystEngComm (2008) 10, 2 162
a=12.5650(19)Å b=9.4769(6)Å c=10.9297(9)Å
α=90° β=90° γ=90°
Cyclotrimethylene-trinitramine
C3N6O6D6
CrystEngComm (2008) 10, 2 162
a=12.6319(15)Å b=9.5554(14)Å c=11.0036(22)Å
α=90.0° β=90.0° γ=90.0°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3344(6)Å b=11.822(3)Å c=4.7387(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3563(6)Å b=11.443(2)Å c=4.6166(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3706(6)Å b=11.204(2)Å c=4.5341(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3728(5)Å b=11.0359(17)Å c=4.4782(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.8778(13)Å b=10.155(4)Å c=4.4175(7)Å
α=90° β=90° γ=90°
Serine hydrate
C3D7NO3,D2O1
CrystEngComm (2008) 10, 12 1758
a=9.3701(14)Å b=11.1831(10)Å c=4.52938(59)Å
α=90° β=90° γ=90°
Serine hydrate
C3D7NO3,D2O1
CrystEngComm (2008) 10, 12 1758
a=9.8641(14)Å b=10.09910(93)Å c=4.39860(65)Å
α=90° β=90° γ=90°
C12H20N14O14
C12H20N14O14
CrystEngComm (2012) 14, 10 3742
a=7.7843(16)Å b=12.857(3)Å c=13.002(3)Å
α=113.73(3)° β=106.34(3)° γ=92.43(3)°
2,4,6,8,10,12-hexanitrohexaazaisowurtzitane:
C13.33H15.67N16O18.67
CrystEngComm (2012) 14, 10 3742
a=15.7503(9)Å b=20.5096(13)Å c=23.2073(13)Å
α=90° β=90.092(2)° γ=90°
2,4,6,8,10,12-hexanitrohexaazisowurtzitane:
C24H60N21O15P3
CrystEngComm (2012) 14, 10 3742
a=18.8930(3)Å b=12.07295(13)Å c=21.8241(4)Å
α=90° β=114.977(2)° γ=90°
2,4,6,8,10,12-hexanitrohexaazaisowurtzitane: 1,4-dioxane (1:4) Co-crystal
C10H17N6O9.50
CrystEngComm (2012) 14, 10 3742
a=10.3061(3)Å b=10.7691(3)Å c=14.5298(4)Å
α=73.897(2)° β=89.527(2)° γ=85.057(2)°
[Mn6(EthSal)6(EtOH)6(Me2COOPhen)2O2]
[Mn6(EthSal)6(EtOH)6(Me2COOPhen)2O2]
Dalton Transactions (2009) 25 4858-4867
a=12.7241(13)Å b=23.184(7)Å c=14.962(2)Å
α=90° β=108.029(7)° γ=90°
[Mn6O2(EthSal)6(EtOH)4(NaphtCOO)2(H2O)2]
[Mn6O2(EthSal)6(EtOH)4(NaphtCOO)2(H2O)2]
Dalton Transactions (2009) 25 4858-4867
a=16.009(2)Å b=19.7972(15)Å c=14.6045(17)Å
α=90° β=112.994(10)° γ=90°
[Mn6O2(EthSal)6(EtOH)4(NaphtCOO)2(H2O)2]
[Mn6O2(EthSal)6(EtOH)4(NaphtCOO)2(H2O)2]
Dalton Transactions (2009) 25 4858-4867
a=15.7129(17)Å b=19.6097(12)Å c=14.3635(14)Å
α=90° β=112.834(8)° γ=90°
[Mn6O2(EthSal)6(EtOH)4(NaphtCOO)2(H2O)2]
[Mn6O2(EthSal)6(EtOH)4(NaphtCOO)2(H2O)2]
Dalton Transactions (2009) 25 4858-4867
a=14.963(4)Å b=19.358(3)Å c=14.165(4)Å
α=90° β=110.929(14)° γ=90°
[Mn3(BPy)4(cht)2][ClO4]3
[Mn3(BPy)4(cht)2][ClO4]3
Dalton Transactions (2009) 36 7390-7395
a=11.549(2)Å b=21.720(4)Å c=12.991(3)Å
α=90° β=94.04(3)° γ=90°
[Mn3(BPy)4(cht)2][ClO4]3
[Mn3(BPy)4(cht)2][ClO4]3
Dalton Transactions (2009) 36 7390-7395
a=11.331(2)Å b=21.547(4)Å c=12.817(3)Å
α=90° β=93.67(3)° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=13.0765(5)Å b=7.0982(4)Å c=15.2455(5)Å
α=90° β=90° γ=90°
[Mn6(EthSal)6(EtOH)6(Me2COOPhen)2O2]
[Mn6(EthSal)6(EtOH)6(Me2COOPhen)2O2]
Dalton Transactions (2009) 25 4858-4867
a=12.5241(8)Å b=22.836(3)Å c=14.6696(10)Å
α=90° β=108.097(4)° γ=90°
[Mn6(EthSal)6(EtOH)6(Me2COOPhen)2O2]
[Mn6(EthSal)6(EtOH)6(Me2COOPhen)2O2]
Dalton Transactions (2009) 25 4858-4867
a=12.4723(13)Å b=22.703(5)Å c=14.5813(15)Å
α=90° β=108.186(6)° γ=90°
[Mn3(BPy)4(cht)2][ClO4]3
[Mn3(BPy)4(cht)2][ClO4]3
Dalton Transactions (2009) 36 7390-7395
a=11.897(2)Å b=22.067(4)Å c=13.312(3)Å
α=90° β=93.82(3)° γ=90°
C7H4NiO5,2(H2O)
C7H4NiO5,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 24 6401-6410
a=8.8079(3)Å b=8.8079(3)Å c=21.1663(6)Å
α=90° β=90° γ=120°
C7H4MnO5,2(H2O)
C7H4MnO5,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 24 6401-6410
a=9.0553(2)Å b=9.0553(2)Å c=10.8872(3)Å
α=90° β=90° γ=120°
Fe gallate dihydrate
C7H3FeO5,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 24 6401-6410
a=8.6716(4)Å b=8.6716(4)Å c=10.8650(5)Å
α=90° β=90° γ=120°
[Cu2(OH)2(H2O)2(tmen)2][ClO4]2
[Cu2(OH)2(H2O)2(tmen)2][ClO4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=7.7554(3)Å b=15.0450(4)Å c=11.2606(4)Å
α=90° β=106.887(2)° γ=90°
[Cu2(OH)2(H2O)2(tmen)2][ClO4]2
[Cu2(OH)2(H2O)2(tmen)2][ClO4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=7.6403(3)Å b=14.7724(4)Å c=11.1904(4)Å
α=90° β=107.386(3)° γ=90°
[Cu2(OH)2(H2O)2(tmen)2][ClO4]2
[Cu2(OH)2(H2O)2(tmen)2][ClO4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=7.5255(4)Å b=14.4578(5)Å c=11.1416(4)Å
α=90° β=108.311(2)° γ=90°
[Cu2(OH)2(bipy)2][BF4]2
[Cu2(OH)2(bipy)2][BF4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=13.312(6)Å b=15.054(7)Å c=6.245(2)Å
α=90° β=115.06(2)° γ=90°
[Cu2(OH)2(bipy)2][BF4]2
[Cu2(OH)2(bipy)2][BF4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=13.323(2)Å b=15.038(3)Å c=6.2630(6)Å
α=90° β=115.043(8)° γ=90°
[Cu2(OH)2(H2O)2(tmen)2][Cu2(OH)2(H2O)(tmen)2][ClO4]4
[Cu2(OH)2(H2O)2(tmen)2][Cu2(OH)2(H2O)(tmen)2][ClO4]4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=11.0214(10)Å b=14.705(3)Å c=16.0463(18)Å
α=62.486(12)° β=81.394(7)° γ=69.543(11)°
[Cu2(OH)2(bipy)2][BF4]2
[Cu2(OH)2(bipy)2][BF4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=13.0669(18)Å b=14.932(2)Å c=6.1859(5)Å
α=90° β=114.558(7)° γ=90°
[Cu2(OH)2(bipy)2][BF4]2
[Cu2(OH)2(bipy)2][BF4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=12.8135(15)Å b=14.810(2)Å c=6.1079(4)Å
α=90° β=114.240(7)° γ=90°
C48H44Gd2N2O14
C48H44Gd2N2O14
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=20.0734(2)Å b=20.0734(2)Å c=9.13850(10)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=22.4915(6)Å b=22.4915(6)Å c=9.1640(3)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=22.4953(9)Å b=22.4953(9)Å c=9.1830(6)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=22.0678(4)Å b=22.0678(4)Å c=9.1203(3)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=21.5853(2)Å b=21.5853(2)Å c=9.04340(10)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=21.3751(2)Å b=21.3751(2)Å c=9.00870(10)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=20.8918(2)Å b=20.8918(2)Å c=8.9248(2)Å
α=90° β=90° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=20.7490(3)Å b=20.7490(3)Å c=8.8988(2)Å
α=90° β=90° γ=90°
[Mn12O12(tBuCH2CO2)16(H2O)4].MeNO2.0.85CH2Cl2
[Mn12O12(tBuCH2CO2)16(H2O)4].MeNO2.0.85CH2Cl2
Chemical communications (Cambridge, England) (2010) 46, 11 1881-1883
a=15.8368(4)Å b=16.4179(5)Å c=27.3955(7)Å
α=76.817(2)° β=78.1610(10)° γ=78.264(2)°
[Mn12O12(tBuCH2CO2)16(H2O)4]
[Mn12O12(tBuCH2CO2)16(H2O)4]
Chemical communications (Cambridge, England) (2010) 46, 11 1881-1883
a=15.0148(19)Å b=15.1418(19)Å c=26.7583(19)Å
α=76.184(9)° β=76.208(8)° γ=79.415(8)°
[Mn12O12(tBuCH2CO2)16(H2O)4].0.75MeNO2.0.5CH2Cl2
[Mn12O12(tBuCH2CO2)16(H2O)4].0.75MeNO2.0.5CH2Cl2
Chemical communications (Cambridge, England) (2010) 46, 11 1881-1883
a=15.3530(11)Å b=15.5310(11)Å c=26.7020(12)Å
α=76.669(5)° β=76.441(5)° γ=78.069(5)°
[Mn12O12(tBuCH2CO2)16(H2O)4].MeNO2.CH2Cl2
[Mn12O12(tBuCH2CO2)16(H2O)4].MeNO2.CH2Cl2
Chemical communications (Cambridge, England) (2010) 46, 11 1881-1883
a=16.099(4)Å b=16.702(4)Å c=27.570(6)Å
α=76.585(4)° β=78.042(4)° γ=77.809(4)°
[Mn12O12(tBuCH2CO2)16(H2O)4].2MeNO2
[Mn12O12(tBuCH2CO2)16(H2O)4].2MeNO2
Chemical communications (Cambridge, England) (2010) 46, 11 1881-1883
a=16.0888(10)Å b=16.6899(10)Å c=27.5390(17)Å
α=76.5270(10)° β=78.0850(10)° γ=77.7050(10)°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.8887(8)Å b=4.9700(3)Å c=20.9607(19)Å
α=90° β=91.546(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.7925(11)Å b=4.9356(5)Å c=20.415(5)Å
α=90° β=92.266(14)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.5438(6)Å b=4.8464(3)Å c=19.203(3)Å
α=90° β=93.648(7)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.3706(7)Å b=4.7918(3)Å c=18.398(3)Å
α=90° β=94.078(8)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.2791(7)Å b=4.7643(3)Å c=17.9649(17)Å
α=90° β=93.960(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=3.8938(4)Å b=5.5612(6)Å c=28.566(8)Å
α=90° β=90° γ=90°
L-alanine-d8
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=6.0186(6)Å b=12.3298(11)Å c=5.7828(4)Å
α=90° β=90° γ=90°
L-alanine-d8
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.9004(10)Å b=12.298(2)Å c=5.7626(8)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.8204(9)Å b=12.2496(18)Å c=5.7419(8)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.7830(5)Å b=12.2194(9)Å c=5.7287(4)Å
α=90° β=90° γ=90°
L-alanine-d8
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.7345(4)Å b=12.1746(7)Å c=5.7095(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.5556(3)Å b=11.9110(7)Å c=5.6233(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.4850(5)Å b=11.7729(10)Å c=5.5875(5)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.4221(3)Å b=11.6457(6)Å c=5.5564(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.2815(5)Å b=11.3765(10)Å c=5.4879(5)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.2459(4)Å b=11.3088(8)Å c=5.4696(4)Å
α=90° β=90° γ=90°
C12H8Cu2O14,4(CH6N3),2(H2O)
C12H8Cu2O14,4(CH6N3),2(H2O)
CrystEngComm (2010) 12, 9 2516
a=11.1332(5)Å b=13.4098(7)Å c=18.367(2)Å
α=90° β=90° γ=90°
C12H8Cu2O14,4(CH6N3),2(H2O)
C12H8Cu2O14,4(CH6N3),2(H2O)
CrystEngComm (2010) 12, 9 2516
a=11.5200(4)Å b=14.4315(7)Å c=18.012(3)Å
α=90° β=90° γ=90°
C12H8Cu2O14,4(CH6N3),2(H2O)
C12H8Cu2O14,4(CH6N3),2(H2O)
CrystEngComm (2010) 12, 9 2516
a=11.716(7)Å b=14.713(9)Å c=17.934(11)Å
α=90° β=90° γ=90°
L-glutamyl-L-cysteinylglycine
C10H17N3O6S1
CrystEngComm (2010) 12, 9 2587
a=5.3033(3)Å b=8.2132(5)Å c=26.874(4)Å
α=90° β=90° γ=90°
L-glutamyl-L-cysteinylglycine
C10H17N3O6S1
CrystEngComm (2010) 12, 9 2587
a=5.6163(5)Å b=8.7795(8)Å c=27.999(2)Å
α=90° β=90° γ=90°
L-glutamyl-L-cysteinylglycine
C10H17N3O6S1
CrystEngComm (2010) 12, 9 2587
a=5.3892(3)Å b=8.4564(4)Å c=27.564(4)Å
α=90° β=90° γ=90°
L-glutamyl-L-cysteinylglycine
C10H17N3O6S1
CrystEngComm (2010) 12, 9 2587
a=5.2748(2)Å b=8.3459(3)Å c=25.496(3)Å
α=90° β=90° γ=90°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.8746(14)Å b=6.4011(10)Å c=8.980(3)Å
α=74.05(2)° β=83.54(2)° γ=80.468(18)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.835(3)Å b=6.310(2)Å c=8.895(7)Å
α=74.62(4)° β=84.12(5)° γ=80.67(4)°